PCM
GMED icon

Palouse Capital Management’s Globus Medical GMED Stock Holding History

Palouse Capital Management’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$109K Hold
1,383
– – 0.07% 94
2026
Q1 		$119K Sell
1,383
-749
-35% -$67.2K 0.08% 85
2025
Q4 		$186K Sell
2,132
-1,224
-36% -$92.9K 0.12% 73
2025
Q3 		$192K Sell
3,356
-24
-0.7% -$1.38K 0.12% 73
2025
Q2 		$199K Buy
3,380
+1,514
+81% +$97.8K 0.13% 64
2025
Q1 		$137K Hold
1,866
– – 0.09% 82
2024
Q4 		$154K Hold
1,866
– – 0.1% 79
2024
Q3 		$133K Sell
1,866
-1,226
-40% -$86.5K 0.08% 85
2024
Q2 		$212K Buy
+3,092
New +$185K 0.14% 63
2020
Q1 		– Sell
-4,581
Closed -$270K – 81
2019
Q4 		$270K Sell
4,581
-1,648
-26% -$89.5K 0.1% 67
2019
Q3 		$318K Sell
6,229
-261
-4% -$12.4K 0.12% 71
2019
Q2 		$275K Buy
+6,490
New +$282K 0.1% 74
2016
Q4 		– Sell
-11,136
Closed -$251K – 99
2016
Q3 		$251K Buy
+11,136
New +$262K 0.11% 72
2016
Q1 		– Sell
-7,298
Closed -$203K – 102
2015
Q4 		$203K Buy
+7,298
New +$183K 0.08% 105

Other funds holding GMED

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return
AAS
Annex Advisory Services Brookfield, Wisconsin $5.86B AUM 21.83% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
VNIM
Vaughan Nelson Investment Management Houston, Texas $11.3B AUM 53% 1-Year Est. Return
CF
Covea Finance Paris, France $3.17B AUM 35.01% 1-Year Est. Return
SFA
Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
OLA
Oliver Luxxe Assets Gladstone, New Jersey $680M AUM 47.51% 1-Year Est. Return
AHIA
Andrew Hill Investment Advisors Naples, Florida $135M AUM 50.1% 1-Year Est. Return

Palouse Capital Management's GMED Position: Q2 2026 in Review

Palouse Capital Management held its Globus Medical (GMED) position steady in Q2 2026 at 1,383 shares worth $109K. The position accounts for 0.07% of the portfolio, ranked #94.

Palouse Capital Management first reported a position in GMED in Q4 2015 and has held it in 14 quarters since. The position peaked at $318K in Q3 2019. 99 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • Palouse Capital Management held 1,383 shares of Globus Medical worth $109K as of Q2 2026.
  • Palouse Capital Management left its Globus Medical share count unchanged in Q2 2026.
  • Globus Medical made up 0.07% of Palouse Capital Management's portfolio in Q2 2026, its #94 holding.
  • Palouse Capital Management first reported a position in Globus Medical in Q4 2015 and has held it in 14 quarters since.
  • Palouse Capital Management's Globus Medical position peaked at $318K in Q3 2019.
  • 99 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Palouse Capital Management's 13F filing for Q2 2026, filed 8 Jul 2026.